StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.10−0.00 (-0.45%)

Close on Nov 18, 2026Market cap $57.73MP/E –Yield –

OKYO Pharma cash

Cash and short-term investments held at the end of each period.

OKYO Pharma's cash was $14.59M at Mar 31, 2026. For fiscal 2026 it was $14.59M, up 835.0% from the year before. The highest annual figure on record is $14.59M in fiscal 2026.

Annual cash

PeriodPeriod endValueChange
FY2026Mar 31, 2026$14.59M+835.0%
FY2025Mar 31, 2025$1.56M+88.8%
FY2024Mar 31, 2024$826.85K-79.6%
FY2023Mar 31, 2023$4.05M+49.8%
FY2022Mar 31, 2022$2.70M-60.8%
FY2021Mar 31, 2021$6.89M+2825.6%
FY2020Mar 31, 2020$235.49K-62.5%
FY2019Mar 31, 2019$627.62K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ1 2026Mar 31, 2026$14.59M+440.4%
Q4 FY2025CQ1 2025Mar 31, 2025$1.56M-77.3%
Q4 FY2024CQ1 2024Mar 31, 2024$826.85K+251.1%
Q4 FY2023CQ1 2023Mar 31, 2023$4.05M+544.6%
Q4 FY2022CQ1 2022Mar 31, 2022$2.70M–
Q4 FY2021CQ1 2021Mar 31, 2021$6.89M–
Q4 FY2020CQ1 2020Mar 31, 2020$235.49K–
Q4 FY2019CQ1 2019Mar 31, 2019$627.62K–

More OKYO Pharma figures

See a number that looks wrong?